The Scientific Advisors team at Xenetic Biosciences provides expert guidance and insights on the development of the XCART platform, leveraging their extensive knowledge in immunology and cancer biology. They collaborate with research and clinical teams to ensure alignment with scientific innovation, regulatory standards, and patient-specific approaches, ultimately enhancing the efficacy of personalized CAR T therapies.
View all